Infantile Hemangiomas of the Head and Neck: A Single-Center Experience

Children (Basel). 2024 Mar 6;11(3):311. doi: 10.3390/children11030311.

Abstract

Background: Infantile hemangiomas (IHs) are the most common benign vascular tumors of infancy. Methods: We report our experiences with 248 patients with head and neck IHs. Results: The median admission age was 4 months, and the female/male ratio was 2.18. Among the cases, 45% were followed by no treatment. No local complications were observed in any of these patients. Propranolol was provided to all patients who received medical treatment. The median duration of treatment was 12 months (1-30 months), and the median follow-up period of all patients was 14 months (0-118 months). The treatment response was 98%. The complication rate was 17%, and children aged between 3 and 9 months accounted for 60% of the patients who developed complications. Most of the complications were local complications, such as ulceration and bleeding. Conclusions: Although most IHs regress spontaneously, complications may occur. Propranolol alone is an effective treatment option, and early treatment initiation increases the success rate.

Keywords: complications; head and neck; infantile hemangioma; propranolol; treatment.

Grants and funding

This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.